Talk:Schizophrenia

NOTE: The {{editintro}} template atop the article page should be removed prior approval.

References

The "references" section built incorrectly. You should list all the books used in this article at the bibliography subpage. & then list all the notes like <ref>Name, Year. page number.</ref> within the article. And name the section "Notes"

(Chunbum Park 11:20, 5 January 2008 (CST))

I'm not sure I understand. There are no books used in the article, only journal articles. The reference style I'm following seems fairly standard with other medical articles. If I've missed something here, let me know. Richard Pettitt 00:19, 7 January 2008 (CST)

Oh, books, or scholarly journal articles. 1) ppl want in which page you find the info within the article 2) it takes too much space & gets too complicated to copy-paste author date title chapter title isbn publisher copyright etc. So... all the author title date isbn publisher thing goes on the bibliography page. on the "notes section" within the mainspace article you just have "name, date. pp.x". See Japanese invasions of Korea (1592-1598). (Chunbum Park 15:16, 9 January 2008 (CST))

From what I know, the usual convention is to list which pages the article is found within the journal, but not to list which pages within the article you've found the material. Secondly, the references style I'm using isn't much work at all. Using pubmed.com gives you a PMID number which I plug into a template [1] and it does all the work for me. (Believe me, I'm not about to do more work than I have to.) That's why I'm leaving things the way they are. :) Richard Pettitt 13:39, 18 January 2008 (CST)

WHO study

I believe a WHO study showed that people who had less access to antipsychic meds had a higher quality of life than those who could afford the meds. I'm assuming this is the "in a glass jar" effect of being on meds. I'm not advocating no meds, but i think this data is something that should be mentioned and is significant.

I also believe I read that 2/3 of homeless in Los Angeles are schizophrenic. Tom Kelly 21:39, 14 January 2008 (CST)

Ok, 2/3 seems too high. Tom Kelly 22:14, 15 January 2008 (CST)

I'm not familiar with this WHO study. Could you dig it up? Also, I added a study on the prevalence of schizophrenia among the homeless.Richard Pettitt

effect of war on schizophrenia

I believe this would be an important section to the article.Tom Kelly 21:47, 14 January 2008 (CST)

percentage of schizophrenics who chain smoke

can you say self medicate? One of those 2,000+ chemicals in cigarette smoke must be doing something we have not yet discovered. Tom Kelly 21:47, 14 January 2008 (CST)

I added something on cigarettes under the treatment section.Richard Pettitt

I know that one hypothesis, theory, and some preliminary data predict that another chemical in cigarettes may be the chemical they self-medicate with (because nicotine alone doesn't explain the smoking. I will ask around for more info. Tom Kelly 22:10, 15 January 2008 (CST)

Yes, tobacco contains monoamine oxidase inhibitors (harman, or something like that), and clinical research suggested that they are at least in great part responsible for reinforcement of the urge to self-administer tobacco. OTOH, MAOI can cause schizophrenia-like symptoms. There's definitely something to dig here, IMO. The research I have in mind was done in France. Gotta go. Pierre-Alain Gouanvic 13:24, 16 January 2008 (CST)

Neuropharmacology. 2007 May;52(6):1415-25. Epub 2007 Feb 20.

Tranylcypromine enhancement of nicotine self-administration.

Moreover, an increase in extracellular dopamine in the nucleus accumbens was detected, using microdialysis, following nicotine (60 microg/kg) injection in tranylcypromine pre-treated rats. Depending on the time of tranylcypromine pretreatment (20 or 1 h), MAO activity was decreased by 72% and 99% and nicotine intake at day 5 was increased by 619 and 997%, respectively. Taken together, these results indicate that in a stringent self-administration acquisition test, MAO inhibition increases the rewarding effect of low doses of nicotine, possibly via a dopamine-dependent mechanism.

Schizophrenia is an hyperdopaminergic disorder, IMAOs cause dopamine elevations; high dopamine contributes to the reinforcement of tobacco addiction; schizophrenics require lower doses of the IMAO in tobacco to get the reinforcing effect. IMO. Pierre-Alain Gouanvic 19:20, 17 January 2008 (CST)

Schizophrenia is a hyper- and hypo-dopaminergic disorder: mesolimbic and mesocorticol dopamine pathways, respectively. (I should probably get around to adding that to the article). So while what you're saying about nicotine's pharmacological effects are true, I believe that nicotine is consumed in an attempt to raise dopaminergic functioning to reduce negative symptoms, rather than for its pleasurable effects. Ideally I'd like an article that speaks more directly to the connection between nicotine's MAO inhibition action and schizophrenia before adding this to the article. Also, I've never heard of a MAOI-schizophrenia connection. I'd be interested in learning more if you could find that research you've mentioned.Richard Pettitt 13:39, 18 January 2008 (CST)

keyboard.problems...: Drugs of abuse, such as D-amphetamine, cocaine, morphine, or heroin, share the ability to cause addiction in humans and to increase release of dopamine (DA) in the nucleus accumbens...However, animal experiments indicate some discrepancies between the effects of nicotine and those of other drugs of abuse. For example, the stimulation of DA release in the nucleus accumbens after several nicotine injections remains controversial...One of the most striking differences between the effects of nicotine and those of other drugs of abuse concerns its locomotor effects. Although psychostimulants and opiates induce a substantial locomotor hyperactivity both in rats and mice, nicotine is a weak locomotor stimulant in rats and generally fails to induce locomotor hyperactivity in mice at any dose...Our data suggest that MAOIs contained in tobacco and tobacco smoke act in synergy with nicotine to enhance its rewarding effects. PMID: 16395299 Monoamine Oxidase Inhibitors Allow Locomotor and Rewarding Responses to Nicotine sorry...Pierre-Alain Gouanvic 15:32, 18 January 2008 (CST)

but: Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis. PMID: 12116182 Pierre-Alain Gouanvic 16:52, 18 January 2008 (CST)

still: Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.... as you said (in an attempt to raise dopaminergic functioning to reduce negative symptoms) Pierre-Alain Gouanvic 17:05, 18 January 2008 (CST)

I added an article on the link between nicotine as an MOAI and schizophrenia. Let me know what you think. Richard Pettitt 17:24, 19 January 2008 (CST)

First person account, to fill the gap left by the DSM copyright restriction

Hello,

I wonder if we could use the moving story told by an investigator in the fields of paranoia and schizophrenia research, published in Schizophrenia Bulletin 2007 33(1):166-17: Peer-Professional First-Person Account: Schizophrenia From the Inside—Phenomenology and the Integration of Causes and Meanings, Peter K. Chadwick. See top of page for permissions. Pierre-Alain Gouanvic 19:06, 17 January 2008 (CST)

I think having case studies within mental health articles is a great idea. I'm not sure how we'd use this particular story, however, due to its length. Maybe as a signed article?

I'm going to look to see if I can find any short and concise case studies we can use... Richard Pettitt 13:39, 18 January 2008 (CST) Update: I`ve emailed a professor for use of a case report he wrote... hopefully he gets back to me soon. --Richard Pettitt 10:05, 23 January 2008 (CST)

No first person accounts in the article. I addressed this with Pierre-Alain on another article. --Michael J. Formica 17:12, 27 January 2008 (CST)